On November 26th, Gelonhui reported that Jinkai Life Science (301509.SZ) announced its plan to reduce its shares by no more than 3,612,000 shares (3% of the total share capital) through block trading and bulk trading. Blue Zone Fund also plans to reduce its shares by no more than 3,612,000 shares (3% of the total share capital) through block trading and bulk trading. Qingsong Investment also plans to reduce its shares by no more than 3,612,000 shares (3% of the total share capital) through block trading and bulk trading.
金凯生科(301509.SZ)：启鹭投资、蓝区基金、青松投资拟合计减持不超过9%股份
GenScript Biotech Corporation (301509.SZ): Qilu Investment, Blue Zone Fund, and Qingsong Investment plan to collectively reduce their shareholding by no more than 9%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated